| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |